| Product NDC: | 43063-095 |
| Proprietary Name: | Hydroxyzine Hydrochloride |
| Non Proprietary Name: | Hydroxyzine |
| Active Ingredient(s): | 25 mg/1 & nbsp; Hydroxyzine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43063-095 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040808 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070629 |
| Package NDC: | 43063-095-06 |
| Package Description: | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-095-06) |
| NDC Code | 43063-095-06 |
| Proprietary Name | Hydroxyzine Hydrochloride |
| Package Description | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-095-06) |
| Product NDC | 43063-095 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydroxyzine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070629 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | HYDROXYZINE HYDROCHLORIDE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antihistamine [EPC],Histamine Receptor Antagonists [MoA] |